PsyAccess
Spravato®Registry-verifiedDesignated-centers model

Universitäre Psychiatrische Kliniken Basel (UPK)

Basel, Switzerland

Treatment & access

  • Treatments offeredesketamine (Spravato)
  • Access routepublic_reimbursed
  • Price informationReimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 61 325 51 11
  • Websitehttps://www.upk.ch/

About this provider

Universitäre Psychiatrische Kliniken (UPK) Basel is the university psychiatric hospital for the Basel region, based at Wilhelm Klein-Strasse 27. Its Centre for Affective, Stress and Sleep Disorders (ZASS) runs an outpatient clinic for affective disorders and interventional psychiatry, offering outpatient ketamine-based therapy and electroconvulsive therapy for severe and difficult-to-treat depression, alongside inpatient wards for depression and bipolar disorders. Referrals to the outpatient ketamine programme are made by physicians via the ZASS secretariat, and a 24-hour central admission service operates on campus.

Services & programs

  • Centre for Affective, Stress and Sleep Disorders (ZASS)
  • Outpatient clinic for affective disorders and interventional psychiatry
  • Outpatient ketamine therapy (physician referral via ZASS)
  • Electroconvulsive therapy (ECT), outpatient and inpatient
  • Inpatient wards for depression and bipolar disorders
  • 24-hour patient admission and emergency psychiatry

Common questions

How do I access ketamine-based treatment at UPK Basel?

UPK states that outpatient ketamine therapy at the ZASS centre is arranged via specialist physician referral (zass@upk.ch or the secretariat on +41 61 325 50 97). For nasal esketamine (Spravato) under Swiss basic insurance, a treating psychiatrist must confirm eligibility and obtain the insurer's cost approval (Kostengutsprache) before the first dose.

Is Spravato reimbursed by Swiss basic insurance (OKP)?

Yes, under a Limitatio: adults 18-74 with a depressive episode that has not responded to at least two antidepressants plus one augmentation attempt, illness severity CGI-S of 5 or more, prior insurer approval before the first dose, and reimbursement for a maximum of 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

Verification

This record was taken directly from an official registry or program list and is re-checked on a rolling cadence.

Spotted an error? See our methodology for how records are checked and how to report a correction.